The weekly cardiovascular update from ACC.org Editor-in-Chief Kim Eagle, MD, MACC, covering the hottest cardiovascular topics, from new clinical guidelines to practice-changing research and innovative quality initiatives and tools.
Eagle’s Eye View: Your Weekly CV Update From ACC.org (Week of Jan. 17)
This week’s View highlights the use of ICD therapy in ischemic vs. non-ischemic cardiomyopathy; what are the (FDG)-positron emission tomography (PET) and MRI findings, and abnormalities in patients with COVID-19; and a meta-analysis examining oral anticoagulation in AFib.
Eagle’s Eye View: Your Weekly CV Update From ACC.org (Week of Jan. 10)
This week’s View discusses the one-year outcomes of blinded physiological assessment of residual ischemia after successful PCI (DEFINE PCI); delineating whether coronary artery spasm is epicardial, microvascular, or both; and the comparison of different strategies for identifying cardiac testing in patients with chest pain.
Eagle’s Eye View: Your Weekly CV Update From ACC.org (Week of Dec. 22)
This week’s View looks at differences in results of the REDUCE-IT (Reduction of Cardiovascular Events With Icosapent Ethyl-Intervention Trial) and STRENGTH (Long-Term Outcomes Study to Assess Statin Residual Risk With Epanova in High Cardiovascular Risk Patients With Hypertriglyceridemia) trials and if they can be explained by the active and comparator oils on lipid traits and C-reactive protein (CRP).
Eagle’s Eye View: Your Weekly CV Update From ACC.org (Week of Dec. 13)
This week’s View examines the clinical course and short-term outcomes of suspected myocarditis following COVID-19 vaccination in patients 21 years of age; the effect of empagliflozin in patients with heart failure across the spectrum of LVEF; and the safety and immunogenicity profiles of different COVID-19 vaccine booster regimens.
Eagle’s Eye View: Your Weekly CV Update From ACC.org (Week of Dec. 6)
This week’s View examines whether high-grade premature ventricular contractions (PVCs) during stress testing predict mortality in asymptomatic individuals; trends in transcatheter mitral valve therapies in the United States; and key perspectives on the newly released ACC/AHA/SCAI Coronary Revascularization Guideline.
Eagle’s Eye View: Your Weekly CV Update From ACC.org (Week of Nov. 29, Part 2)
This episode of Eagle’s Eye View examines the long-term outcomes for patients with left main CAD treated with PCI with drug-eluting stents vs. CABG; a state-of-the-art review on acute aortic syndrome; and the impact of heart disease subtypes on in-hospital mortality of patients with COVID-19.
Gets to the point. No hot air.
Excellent, objective, concise, and very intelligent review of clinically relevant studies. Dr. Eagle brings a tremendous amount of experience to this review which makes it very easy to know how to change your practice based upon these important studies.
Great review app for residents and fellows
Loved it. Shared it with my friends at cards. Thank you!!